FreeStyle Logo
Abbott
This is Abbott’s website for the 17th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD)2024. Abbott’s materials are intended for Health Care Providers of the European Union only. If you require product information for a specific country, please refer to your local Abbott website.
attd attd
alt text alt text

Welcome to Abbott's portal for the Advanced Technologies & Treatments
for Diabetes Conference (ATTD) 2024.

MARCH 8TH | FLORENCE | HALL A

Sensor-based technology has revolutionised glucose monitoring for a wide range of people with diabetes. Prof. Stefano Del Prato will moderate the discussion to:

  • Explore the growing clinical evidence for the use of glucose sensing technology in different populations
  • Discover new integrations and practical applications advancing diabetes care
  • Preview the future of diabetes care through innovations in sensing technology

The session will end with a look at new developments in diabetes care and an open Q&A with our panel of experts. 

AGENDA

11:00 - 11:05 a.m.

SPARK THE CONVERSATION

PROF. STEFANO DEL PRATO

Interdisciplinary Research Center "HealthScience", Sant'Anna School of Advanced Studies, Pisa, Italy

11:05 - 11:30 a.m.



Prof. Battelino and Bertuzzi Prof. Battelino and Bertuzzi

UNVEILING THE ROLE OF GLUCOSE SENSING TECHNOLOGY  FOR PEOPLE WITH TYPE 2 DIABETES ON NON-INTENSIVE  INSULINTHERAPY

PROF. TADEJ BATTELINO

University Medical Center Ljubljana, and Faculty of Medicine, University of Ljubljana, Slovenia

DR. FEDERICO BERTUZZI

Diabetology Unit, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy

11:30 - 12:05 a.m.

 

Dr Winhofer and Wilmot Dr Winhofer and Wilmot

SEAMLESS SYNERGY: ENHANCING INTEGRATION OF GLUCOSE  SENSING TECHNOLOGY WITH INSULIN PENS AND AID SYSTEMS 

DR. YVONNE WINHOFER

Department of Internal Medicine III, Division of Endocrinology and  Metabolism, Medical University of Vienna, Austria

DR. EMMA WILMOT

University Hospitals of Derby and Burton NHS Foundation Trust and University of Nottingham, United Kingdom

12:05 - 12:30 p.m.

W Scott Harper W Scott Harper

PIONEERING INTO TOMORROW TOGETHER

SCOTT HARPER

Divisional Vice President, Research and Development Diabetes Care, Abbott, California

12:30 p.m.

FOLLOWED BY Q&A

ADC-87514 v1.0

Home
Contact Us
Abbott Logo

This is a product specific website intended for Health Care Providers of the European Union only. If you live in another country, please contact your Local Abbott office to obtain the correct product information for your country of residence.

The sensor housing, FreeStyle, Libre, and related brand marks are marks of Abbott. Other trademarks are the property of their respective owners.

©️ 2024 Abbott

Do you want to leave this page?

The "Yes" link below will take you to a website other than Abbott Laboratories. Links to other websites are not under the control of Abbott Laboratories, and Abbott Laboratories is not responsible for the content of such websites or any link contained in such websites. Abbott Laboratories is providing these links to you only as a convenience, and the inclusion of any link does not imply endorsement by Abbott Laboratories of the site.

Do you want to leave this page?

Disclaimer

This is a product-specific website intended for HCPs of the European Union only. If you live in another country, please contact your local Abbott office to obtain the correct product information for your country of residence. 

Go Global